NEW YORK (GenomeWeb News) – In a final ruling, the Centers for Medicare & Medicaid Services has decided to reimburse the new molecular pathology claims codes published by the American Medical Association in its payment channel dedicated to laboratory tests.

However, for a minority of tests that require a doctor's interpretation, that portion will be accounted for via the payment pathway for physicians' services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.